The Fra-1-miR-134-SDS22 feedback loop amplifies ERK/JNK signaling and reduces chemosensitivity in ovarian cancer cells

Cell Death Dis. 2016 Sep 29;7(9):e2384. doi: 10.1038/cddis.2016.289.

Abstract

The Fra-1 transcription factor is frequently upregulated in multiple types of tumors. Here we found that Fra-1 promotes miR-134 expression. miR-134 activates JNK and ERK by targeting SDS22, which in turn induces Fra-1 expression and leads to miR-134 upregulation. In addition, miR-134 augmented H2AX S139 phosphorylation by activating JNK and promoted non-homologous end joining (NHEJ)-mediated DNA repair. Therefore, ectopic miR-134 expression reduced chemosensitivity in ovarian cancer cells. Furthermore, miR-134 promotes cell proliferation, migration and invasion of ovarian cancer cells, and enhances tumor growth in vivo. Of particular significance, both Fra-1 and miR-134 are upregulated in ovarian cancer tissues, and Fra-1 and miR-134 expression is positively correlated. High levels of miR-134 expression were associated with a reduced median survival of ovarian cancer patients. Our study revealed that a Fra-1-miR-134 axis drives a positive feedback loop that amplifies ERK/JNK signaling and reduces chemosensitivity in ovarian cancer cells.

MeSH terms

  • 3' Untranslated Regions / genetics
  • Animals
  • Antineoplastic Agents / pharmacology
  • Antineoplastic Agents / therapeutic use*
  • Cell Line, Tumor
  • Cell Movement / drug effects
  • Cell Proliferation / drug effects
  • DNA Repair / drug effects
  • Feedback, Physiological* / drug effects
  • Female
  • Gene Expression Regulation, Neoplastic / drug effects
  • Histones / metabolism
  • Humans
  • MAP Kinase Signaling System / drug effects
  • Mice, Nude
  • MicroRNAs / genetics
  • MicroRNAs / metabolism*
  • Neoplasm Invasiveness
  • Ovarian Neoplasms / drug therapy*
  • Ovarian Neoplasms / genetics
  • Ovarian Neoplasms / metabolism*
  • Phosphorylation / drug effects
  • Phosphoserine / metabolism
  • Protein Phosphatase 1 / metabolism*
  • Proto-Oncogene Proteins c-fos / metabolism*
  • Proto-Oncogene Proteins p21(ras) / metabolism
  • Transcription Factor AP-1 / metabolism
  • Treatment Outcome
  • Up-Regulation / drug effects

Substances

  • 3' Untranslated Regions
  • Antineoplastic Agents
  • H2AX protein, human
  • Histones
  • MIRN134 microRNA, human
  • MicroRNAs
  • PPP1R7 protein, human
  • Proto-Oncogene Proteins c-fos
  • Transcription Factor AP-1
  • fos-related antigen 1
  • Phosphoserine
  • Protein Phosphatase 1
  • HRAS protein, human
  • Proto-Oncogene Proteins p21(ras)